Skip to main content
Top
Published in: European Journal of Clinical Microbiology & Infectious Diseases 7/2005

01-07-2005 | Concise Article

Reactivation of hepatitis B in an HIV-infected patient with antibodies against hepatitis B core antigen as the only serological marker

Authors: A. J. Chamorro, J. L. Casado, D. Bellido, S. Moreno

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 7/2005

Login to get access

Abstract

Presented here is the first report of clinical reactivation of hepatitis B virus (HBV) in an HIV-infected patient who previously had anti-HBc as the only serological marker of past infection (anti-HBc alone). Reactivation occurred after lamivudine was removed from the patient’s antiretroviral treatment regimen due to lack of virological response. HIV-infected patients frequently present anti-HBc alone, and in some cases this serological profile is associated with occult HBV infection. The current case demonstrates the importance of ruling out the possibility of occult infection in this patient group.
Literature
1.
go back to reference Rutsgi V, Hoofnagle J, Guerin J et al (1984) Hepatitis B infection in the acquired immunodeficiency syndrome. Ann Intern Med 101:795–797PubMed Rutsgi V, Hoofnagle J, Guerin J et al (1984) Hepatitis B infection in the acquired immunodeficiency syndrome. Ann Intern Med 101:795–797PubMed
2.
go back to reference Bessesen M, Ives D, Condreay L, Lawrence S, Sherman KE (1999) Chronic active hepatitis B exacerbation in human immunodeficency virus-infected patients following development of resistance to or withdrawal of lamivudine. Clin Infect Dis 28:1032–1035PubMed Bessesen M, Ives D, Condreay L, Lawrence S, Sherman KE (1999) Chronic active hepatitis B exacerbation in human immunodeficency virus-infected patients following development of resistance to or withdrawal of lamivudine. Clin Infect Dis 28:1032–1035PubMed
3.
go back to reference Altfeld M, Rockstroh JK, Addo M, Kupfer B, Pult I, Will H, Spengler U (1998) Reactivation of hepatitis B in a long-term anti-HBs-positive patient with AIDS following lamivudine withdrawal. J Hepatol 29:306–309PubMed Altfeld M, Rockstroh JK, Addo M, Kupfer B, Pult I, Will H, Spengler U (1998) Reactivation of hepatitis B in a long-term anti-HBs-positive patient with AIDS following lamivudine withdrawal. J Hepatol 29:306–309PubMed
4.
go back to reference Neau D, Schvoerer E, Robert D, Dubois F, Dutronc H, Fleury HJ, Ragnaud JM (2000) Hepatitis B exacerbation with a precore mutant virus following withdrawal of lamivudine in a human immunodeficiency virus-infected patient. J Infect 41:192–194PubMed Neau D, Schvoerer E, Robert D, Dubois F, Dutronc H, Fleury HJ, Ragnaud JM (2000) Hepatitis B exacerbation with a precore mutant virus following withdrawal of lamivudine in a human immunodeficiency virus-infected patient. J Infect 41:192–194PubMed
5.
go back to reference Hadler SC, Murphy BL, Schable CA, Heyward WL, Francis DP, Kane MA (1984) Epidemiological analysis of the significance of low-positive test results for antibody to hepatitis B surface and core antigens. J Clin Microbiol 19:521–525PubMed Hadler SC, Murphy BL, Schable CA, Heyward WL, Francis DP, Kane MA (1984) Epidemiological analysis of the significance of low-positive test results for antibody to hepatitis B surface and core antigens. J Clin Microbiol 19:521–525PubMed
6.
go back to reference Joller-Jemelka HI, Wicki AN, Grob PJ (1994) Detection of HBs antigen in “anti-HBc alone” positive sera. J Hepatol 21:269–272PubMed Joller-Jemelka HI, Wicki AN, Grob PJ (1994) Detection of HBs antigen in “anti-HBc alone” positive sera. J Hepatol 21:269–272PubMed
7.
go back to reference Grob P, Jilg W, Bornhak H et al (2000) Serological pattern “anti-HBc alone” report on a work-shop. J Med Virol 62:450–455PubMed Grob P, Jilg W, Bornhak H et al (2000) Serological pattern “anti-HBc alone” report on a work-shop. J Med Virol 62:450–455PubMed
8.
go back to reference Gandhi RT, Wurcel A, Lee H, McGovern B, Boczanowski M, Gerwin R, Corcoran CP, Szczepiorkowski Z, Toner S, Cohen DE, Sax PE, Ukomadu C (2003) Isolated antibody to hepatitis B core antigen in human immunodeficiency virus type-1-infected individuals. Clin Infect Dis 36:1602–1605PubMed Gandhi RT, Wurcel A, Lee H, McGovern B, Boczanowski M, Gerwin R, Corcoran CP, Szczepiorkowski Z, Toner S, Cohen DE, Sax PE, Ukomadu C (2003) Isolated antibody to hepatitis B core antigen in human immunodeficiency virus type-1-infected individuals. Clin Infect Dis 36:1602–1605PubMed
9.
go back to reference Krugman S, Overby LR, Mushahwar IK et al (1979) Viral hepatitis, type B. Studies on natural history and prevention re-examined. N Engl J Med 300:101PubMed Krugman S, Overby LR, Mushahwar IK et al (1979) Viral hepatitis, type B. Studies on natural history and prevention re-examined. N Engl J Med 300:101PubMed
10.
go back to reference Bani-Sadr F, Maillard A, Ponscarme D, Scieux C, Molina JM (2003) Reactivation of HBV replication in HIV-HBV infected patients. Am J Med 114:768–769 Bani-Sadr F, Maillard A, Ponscarme D, Scieux C, Molina JM (2003) Reactivation of HBV replication in HIV-HBV infected patients. Am J Med 114:768–769
11.
go back to reference Piroth L, Binquet C, Vergne M, Minello A, Livry C, Bour JB, Buisson M, Duong M, Grappin M, Portier H, Chavanet P (2002) The evolution of hepatitis B virus serological patterns and the clinical relevance of isolated antibodies to hepatitis B core antigen in HIV infected patients. J Hepatol 36:681–686PubMed Piroth L, Binquet C, Vergne M, Minello A, Livry C, Bour JB, Buisson M, Duong M, Grappin M, Portier H, Chavanet P (2002) The evolution of hepatitis B virus serological patterns and the clinical relevance of isolated antibodies to hepatitis B core antigen in HIV infected patients. J Hepatol 36:681–686PubMed
12.
go back to reference Hofer M, Joller-Jemelka HJ, Grob PJ, Luthy R, Opravil M (1998) Frequent chronic hepatitis B virus infection in HIV-infected patients positive for antibody to hepatitis B core antigen only. Eur J Clin Microbiol Infect Dis 17:6–13PubMed Hofer M, Joller-Jemelka HJ, Grob PJ, Luthy R, Opravil M (1998) Frequent chronic hepatitis B virus infection in HIV-infected patients positive for antibody to hepatitis B core antigen only. Eur J Clin Microbiol Infect Dis 17:6–13PubMed
13.
go back to reference Hino K, Basuni AA, Ireland J, Newell A, Mphahlele J, Smit EJ, Ngui SL, Teo CG, Carman WF (2002) Reappearance of hepatitis B surface antigen in immunocompromised individuals. Reinfection or reactivation? Dig Dis Sci 47:415–418PubMed Hino K, Basuni AA, Ireland J, Newell A, Mphahlele J, Smit EJ, Ngui SL, Teo CG, Carman WF (2002) Reappearance of hepatitis B surface antigen in immunocompromised individuals. Reinfection or reactivation? Dig Dis Sci 47:415–418PubMed
14.
go back to reference Manegold C, Hannoun C, Wywiol A, Dietrich M, Polywka S, Chiwakata CB, Gunther S (2001) Reactivation of hepatitis B virus replication accompanied by acute hepatitis in patients receiving highly active antiretroviral therapy. Clin Infect Dis 32:144–148PubMed Manegold C, Hannoun C, Wywiol A, Dietrich M, Polywka S, Chiwakata CB, Gunther S (2001) Reactivation of hepatitis B virus replication accompanied by acute hepatitis in patients receiving highly active antiretroviral therapy. Clin Infect Dis 32:144–148PubMed
15.
go back to reference Thio CL, Seaberg EC, Skolasky R Jr, Phair J, Visscher B, Munoz A, Thomas DL, Multicenter AIDS Cohort Study (2002) HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS). Lancet 360:1921–1926PubMed Thio CL, Seaberg EC, Skolasky R Jr, Phair J, Visscher B, Munoz A, Thomas DL, Multicenter AIDS Cohort Study (2002) HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS). Lancet 360:1921–1926PubMed
16.
go back to reference Lascar RM, Gilson RJ, Lopes AR, Bertoletti A, Maini MK (2003) Reconstitution of hepatitis B virus (HBV)-specific T cell responses with treatment of human immunodeficiency virus/HBV coinfection. J Infect Dis 188:1815–1819PubMed Lascar RM, Gilson RJ, Lopes AR, Bertoletti A, Maini MK (2003) Reconstitution of hepatitis B virus (HBV)-specific T cell responses with treatment of human immunodeficiency virus/HBV coinfection. J Infect Dis 188:1815–1819PubMed
Metadata
Title
Reactivation of hepatitis B in an HIV-infected patient with antibodies against hepatitis B core antigen as the only serological marker
Authors
A. J. Chamorro
J. L. Casado
D. Bellido
S. Moreno
Publication date
01-07-2005
Publisher
Springer-Verlag
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 7/2005
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-005-1355-1

Other articles of this Issue 7/2005

European Journal of Clinical Microbiology & Infectious Diseases 7/2005 Go to the issue

Announcements

July 2005

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.